…SSION, USE, AND TRANSFER OF SELECT AGENTS AND TOXINS Title 9—Animals and Animal Products PART 121—POSSESSION, USE, AND TRANSFER OF SELECT AGENTS AND TOXINS Footnotes Enhanced Content - Table of Contents Public Comments Enhanced Content - Public Comments This feature is not availa…

…. Changes to the New Technology Add-On Payment Policy for Certain Antimicrobial Products c. Continuation of the Low Wage Index Hospital Policy d. DSH Payment Adjustment and Additional Payment for Uncompensated Care e. Reduction of Hospital Payments for Excess Readmissions f. Hosp…

…. Changes to the New Technology Add-On Payment Policy for Certain Antimicrobial Products c. Continuation of the Low Wage Index Hospital Policy d. DSH Payment Adjustment and Additional Payment for Uncompensated Care e. Reduction of Hospital Payments for Excess Readmissions f. Hosp…

…mended Preventive Services C. Executive Orders on the Affordable Care Act and Reproductive Health D. FDA Approval of Daily Over-the-Counter Oral Contraceptive E. OTC Preventive Products Request for Information F. Transparency in Coverage Under the ACA and Implementing Regulations…

…als (7) Utilities (8) Medical Equipment (9) Medical Supplies (10) Miscellaneous Products (11) Professional, Scientific, and Technical Services (12) Administrative and Facilities Support Services (13) All Other Services (14) Fixed Capital (15) Moveable Capital c. Summary of Price …

…ccines In-Home Administration of COVID-19 Vaccines COVID-19 Monoclonal Antibody Products K. Payment for Medical Nutrition Therapy Services and Related Services III. Other Provisions of the Proposed Rule A. Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs)…

…s in the FFEs and SBE-FPs to offer additional non-standardized plan options per product network type, metal level, inclusion of dental and vision benefit coverage, and service area for PY 2025 and subsequent plan years, if the issuer can demonstrate that these additional non-stan…

…) Non-User-Facing Aspects of Health IT (C) Intellectual Property (D) Faithful Reproductions of Health IT Screenshots (E) Testing and Development c. Maintenance of Certification Requirements 4. Application Programming Interfaces a. Statutory Interpretation and API Policy Principle…

…ormation for Applicable Clinical Trials of Unapproved, Unlicensed, or Uncleared Products for Any Use Overview of Proposal Comments and Response Final Rule C. Submission of Technical and Non-technical Summaries Overview of Proposal Comments and Response Final Rule D. Submission of…

…xemptions Applicable to Food Subject to HACCP Requirements for Fish and Fishery Products ( 21 CFR Part 123 ) or for Juice ( 21 CFR Part 120 ) D. Proposed § 117.5(d)—Exemption Applicable to Food Subject to Part 113—Thermally Processed Low-Acid Foods Packaged in Hermetically Sealed…

…ormation for Applicable Clinical Trials of Unapproved, Unlicensed, or Uncleared Products for Any Use Overview of Proposal Comments and Response Final Rule C. Submission of Technical and Non-technical Summaries Overview of Proposal Comments and Response Final Rule D. Submission of…

… Description of the Proposed Amendment to the Definition of In Vitro Diagnostic Products A. Proposed Amendment B. Legal Basis for the Proposed Amendment 1. In Vitro Diagnostic Test Systems Are Devices 2. Test Systems Manufactured by Laboratories Are Devices 3. FDA's Jurisdiction …

…n a comparable basis with the PPIS data. We also do not use the PPIS data for reproductive endocrinology and spine surgery since these specialties currently are not separately recognized by Medicare, nor do we have a method to blend the PPIS data with Medicare-recognized specialt…

…r the Outpatient Prospective Payment System (OPPS) C. Current FDA Regulation of Products CMS Considers To Be Skin Substitutes 1. Self-determination Under Section 361 of the PHS Act and the Regulations in 21 CFR 1271 (361 HCT/Ps) 2. 510(k) Premarket Notification Submissions, Prema…

…r the Outpatient Prospective Payment System (OPPS) C. Current FDA Regulation of Products CMS Considers To Be Skin Substitutes 1. Self-determination Under Section 361 of the PHS Act and the Regulations in 21 CFR 1271 (361 HCT/Ps) 2. 510(k) Premarket Notification Submissions, Prema…